Melchor Riera

1.1k total citations
35 papers, 356 citations indexed

About

Melchor Riera is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Melchor Riera has authored 35 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 11 papers in Epidemiology and 10 papers in Virology. Recurrent topics in Melchor Riera's work include HIV/AIDS Research and Interventions (19 papers), HIV/AIDS drug development and treatment (13 papers) and HIV Research and Treatment (10 papers). Melchor Riera is often cited by papers focused on HIV/AIDS Research and Interventions (19 papers), HIV/AIDS drug development and treatment (13 papers) and HIV Research and Treatment (10 papers). Melchor Riera collaborates with scholars based in Spain, United States and United Kingdom. Melchor Riera's co-authors include Adrián Curran, Esteban Ribera, David Dalmau, Lluís Force, María Luz Pintos Peñaranda, Vicenç Falcó, Antoni Payeras, Gloria Sampériz, Santiago Moreno and Antonio Antela and has published in prestigious journals such as The Science of The Total Environment, Clinical Infectious Diseases and Frontiers in Immunology.

In The Last Decade

Melchor Riera

33 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melchor Riera Spain 12 226 136 131 86 21 35 356
Marilyn McMurchie Australia 6 297 1.3× 241 1.8× 84 0.6× 94 1.1× 6 0.3× 11 447
Amit C. Achhra Australia 13 330 1.5× 226 1.7× 89 0.7× 297 3.5× 16 0.8× 26 485
Félix Omeñaca Teres Spain 6 193 0.9× 112 0.8× 139 1.1× 66 0.8× 6 0.3× 12 331
P. Puglièse France 14 287 1.3× 147 1.1× 177 1.4× 116 1.3× 8 0.4× 32 489
Margherita Bracchi United Kingdom 7 187 0.8× 126 0.9× 98 0.7× 75 0.9× 4 0.2× 25 268
Judy Johnson United States 14 459 2.0× 424 3.1× 100 0.8× 92 1.1× 61 2.9× 19 617
Sivaporn Gatechompol Thailand 11 242 1.1× 84 0.6× 144 1.1× 125 1.5× 9 0.4× 41 380
Paulo Ricardo de Alencastro Brazil 10 198 0.9× 114 0.8× 88 0.7× 193 2.2× 8 0.4× 17 333
Josef Jost Switzerland 9 280 1.2× 140 1.0× 105 0.8× 44 0.5× 4 0.2× 13 473
Tanakorn Apornpong Thailand 10 134 0.6× 130 1.0× 152 1.2× 129 1.5× 3 0.1× 40 344

Countries citing papers authored by Melchor Riera

Since Specialization
Citations

This map shows the geographic impact of Melchor Riera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melchor Riera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melchor Riera more than expected).

Fields of papers citing papers by Melchor Riera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melchor Riera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melchor Riera. The network helps show where Melchor Riera may publish in the future.

Co-authorship network of co-authors of Melchor Riera

This figure shows the co-authorship network connecting the top 25 collaborators of Melchor Riera. A scholar is included among the top collaborators of Melchor Riera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melchor Riera. Melchor Riera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García‐Gasalla, Mercedes, et al.. (2025). Fiebre Q aguda en Mallorca, 2017-2022. Un problema infraestimado. Enfermedades Infecciosas y Microbiología Clínica. 43(10). 639–644. 1 indexed citations
2.
Riera, Melchor, et al.. (2025). Association between the Planetary Health Diet Index and growth differentiation factor-15: the Seniors ENRICA-2 cohort. GeroScience. 48(1). 679–690. 1 indexed citations
3.
García‐Gasalla, Mercedes, et al.. (2025). Acute Q fever in Majorca island 2017–2022. An underestimated problem. Enfermedades infecciosas y microbiologia clinica (English ed ). 43(10). 639–644.
4.
Riera, Melchor, Rosario Ortolá, Stefanos N. Kales, et al.. (2025). Health and environmental dietary impact: Planetary health diet vs. Mediterranean diet. A nationwide cohort in Spain. The Science of The Total Environment. 968. 178924–178924. 6 indexed citations
5.
Riera, Melchor, Rosario Ortolá, Stefanos N. Kales, et al.. (2025). Planetary health diet, other plant-based diets and risk of type 2 diabetes: a prospective study from the UK Biobank. Cardiovascular Diabetology. 24(1). 376–376.
6.
Valero, Ignacio, Ángela Camacho, Ángela Gutiérrez, et al.. (2023). Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in HIV late presenters. International Journal of Antimicrobial Agents. 63(1). 107016–107016. 2 indexed citations
7.
Riera, Melchor, et al.. (2022). Executive summary of the consensus document of the HIV quality of care indicators. GESIDA updated. Enfermedades infecciosas y microbiologia clinica (English ed ). 40(1). 35–38. 2 indexed citations
8.
Llibre, Josep M., Alexandra Montoliu, JM Miró, et al.. (2019). Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort. HIV Medicine. 20(3). 237–247. 25 indexed citations
9.
Díez‐Fuertes, Francisco, Erick De La Torre Tarazona, Esther Calonge, et al.. (2019). Association of a single nucleotide polymorphism in the ubxn6 gene with long-term non-progression phenotype in HIV-positive individuals. Clinical Microbiology and Infection. 26(1). 107–114. 3 indexed citations
10.
Domingo, Peré, Arkaitz Imaz, Estebán Martínez, et al.. (2014). Effectiveness of ritonavir-boosted protease inhibitor monotherapy in the clinical setting: same results as in clinical trials? The PIMOCS Study Group. Journal of Antimicrobial Chemotherapy. 69(5). 1390–1396. 15 indexed citations
11.
Blanco, José Ramón, Ana María Caro-Murillo, Julián Olalla, et al.. (2013). Safety, Efficacy, and Persistence of Emtricitabine/Tenofovir Versus Other Nucleoside Analogues in Naive Subjects Aged 50 Years or Older in Spain: The TRIP Study. HIV Clinical Trials. 14(5). 204–215. 2 indexed citations
12.
13.
Imaz, Arkaitz, Vicenç Falcó, María Luz Pintos Peñaranda, et al.. (2009). Impact of prior pneumococcal vaccination on clinical outcomes in HIV‐infected adult patients hospitalized with invasive pneumococcal disease. HIV Medicine. 10(6). 356–363. 14 indexed citations
14.
Navarro, Gemma, María Mercedes Nogueras, F. Segura, et al.. (2008). HIV-1 infected patients older than 50 years. PISCIS cohort study. Journal of Infection. 57(1). 64–71. 32 indexed citations
15.
Mont, Lluı́s, Ricardo Ruiz‐Granell, Juan Gabriel Martı́nez, et al.. (2007). Impact of anti-tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: results of the prevention or termination (POT) trial. EP Europace. 10(1). 28–34. 21 indexed citations
16.
Peñaranda, María Luz Pintos, Vicenç Falcó, Antoni Payeras, et al.. (2007). Effectiveness of Polysaccharide Pneumococcal Vaccine in HIV-Infected Patients: a Case-Control Study. Clinical Infectious Diseases. 45(7). e82–e87. 47 indexed citations
17.
Gráses, F., Antonia Costa‐Bauzá, B.M. Simonet, et al.. (2004). Effects of escin on indinavir crystallization time in the urine of patients with HIV-I infection: A multicenter, randomized, open-label, controlled, four-period crossover trial. Clinical Therapeutics. 26(12). 2045–2055. 10 indexed citations
18.
Leyes, María, et al.. (2002). Prevención de la transmisión vertical del VIH-1 en mallorca. impacto de la terapia antirretroviral desde 1995 a 2000. Medicina Clínica. 118(10). 365–370. 3 indexed citations
19.
Riera, Melchor, et al.. (2001). Infecciones invasoras por estreptococos del grupo A: características clínicas y análisis microbiológico de 31 casos. Enfermedades Infecciosas y Microbiología Clínica. 19(8). 371–375. 5 indexed citations
20.
Payeras, Antoni, et al.. (1996). [Pseudomonas spp. infections in patients with HIV infections].. PubMed. 14(9). 519–23. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marilyn McMurchie Breakdown of academic impact, for papers by Amit C. Achhra Breakdown of academic impact, for papers by Félix Omeñaca Teres Breakdown of academic impact, for papers by P. Puglièse Breakdown of academic impact, for papers by Margherita Bracchi Breakdown of academic impact, for papers by Judy Johnson Breakdown of academic impact, for papers by Sivaporn Gatechompol Breakdown of academic impact, for papers by Paulo Ricardo de Alencastro Breakdown of academic impact, for papers by Josef Jost Breakdown of academic impact, for papers by Tanakorn Apornpong
Rankless by CCL
2026